جست‌وجوی استاد و پژوهشگر

Brett Welchمشاهده پروفایل

استادیار

• Psychology
• Communication Disorders
• Voice Disorders
• +۴ مورد دیگر

Brett Welch is an Assistant Professor and Biostatistician at the University of Houston with dual appointments in the Department of Communication Sciences and Disorders and the Department of Psychological, Health, and Learning Sciences within the College of Liberal Arts and Social Sciences. Dr. Welch's educational background includes: Ph.D. in Communication Science and Disorders from the University of Pittsburgh M.S. in Communication Sciences and Disorders from the University of Texas Rio Grande Valley B.S. in Linguistics from the University of Texas at Austin B.A. in Communication Sciences and Disorders – Speech-Language Pathology from the University of Texas at Austin Dr. Welch's research sits at the intersection of psychology and communication. He seeks to understand how psychological processes like personality and psychopathology influence communication behaviors, and conversely, how communication behaviors impact psycho-social well-being. His work leverages quantitative methods, cross-sectional studies, and intensive longitudinal designs to interrogate the dynamic interplay between psychological processes and voice and communication behaviors. This research aims to advance understanding of functional voice disorders, improve assessment of psychopathology, and promote well-being for people with and without communication disorders. Dr. Welch has received several notable awards: Honors Council of Academic Programs in Communication Sciences and Disorders PhD Scholarship (2024) New Century Scholars Doctoral Scholarship from the American Speech-Language-Hearing Foundation (2023) New Investigator Forum from The Voice Foundation (2021) As an academic, Dr. Welch serves as an ad hoc peer reviewer for various scientific journals in speech-language pathology and psychology. He is also a mentor in the Students to Empowered Professional Mentoring Program and a member of the American Speech-Language-Hearing Association. His teaching includes Special Problems: Introduction to Quantitative Modeling (COMD 8398). Dr. Welch maintains an active research program focused on the intersection of psychology and communication, with particular emphasis on voice disorders and their psychological correlates. His work combines biostatistical approaches with clinical insights to advance understanding in this specialized field.

KEMAL OZAN LÜLEمشاهده پروفایل

استادیار

• Internal Medicine
• Endocrinology
• Gastroenterology
• +۶ مورد دیگر

KEMAL OZAN LÜLE is an Assistant Professor at Gaziantep University, Faculty of Medicine, Department of Internal Medicine , with an email contact at ozan@gantep.edu.tr . He holds an ORCID identifier and is registered in the YÖK Academic Information System. Education: Medical License from Dokuz Eylül University (2009–2016), Medical Specialization from Gaziantep University (2017–2021). Professional Experience: Specialist at Gaziantep Abdulkadir Yuksel State Hospital (2021–2024), General Practitioner at Arapgir Ali Özge State Hospital (2016–2017). Administrative Roles: Member of Measurement and Evaluation Board (2024), Internal Medicine Internship Education Coordinator (2024), English Medicine Assistant Coordinator (2024). His research focuses on Internal Medicine , with emphasis on Diabetes , Fatty Liver Disease , Neurocognitive Effects of diabetes treatments, Cancer Development linked to food preparation, Irritable Bowel Syndrome , and Adrenal Incidentaloma . Book Chapters: Development and Natural Course of Diabetic Fatty Liver Disease (2025), Effects of Pharmacological Agents on Neurological Functions (2023), Food Preparation Methods and Cancer (2023). He has co-authored multiple proceedings papers on topics including Temporal Arthritis , Lymphoma , Behçet’s Disease , and Fahr Syndrome , presented at national and international conferences.

Stephen A. Boydمشاهده پروفایل

استاد

• Environmental Chemistry
• Soil Microbiology
• Contaminant Remediation
• +۵ مورد دیگر

Stephen A. Boyd is a University Distinguished Professor in the Department of Plant, Soil and Microbial Sciences within Michigan State University's College of Agriculture and Natural Resources. His research spans environmental chemistry and microbiology with a focus on soil systems. His educational background includes a B.S. in Chemistry from Central Michigan University (1975), and M.S. and Ph.D. in Soil Chemistry from Purdue University (1978, 1980). Dr. Boyd's research investigates organic contaminant movement in soil, microbial/catalytic degradation mechanisms, and remediation technologies for contaminated soils/sediments. His work features innovative approaches including chemically modified clays for contaminant sorption and degradation, mechanistic studies of toxicant interactions with natural/modified clays, and development of in-situ soil modification technologies. He extensively examines biodegradation of xenobiotics (particularly PCB reductive dechlorination) and bioavailability of soil-bound contaminants to degrading bacteria. His 15 most recent publications reveal strong trends in clay-based contaminant immobilization, pharmaceutical/water pollutant interactions, dioxin chemistry, and nanomaterial applications for environmental remediation, with dominant fields being environmental chemistry, soil science, and contaminant toxicology. University Distinguished Professor (MSU, 2005) Jackson Award in Soil Science (SSSA, 2004) Highly Cited Researcher (Institute for Scientific Information, 2002) Distinguished Faculty Award (MSU, 2001) Soil Science Research Award (SSSA, 1999) Dr. Boyd has secured significant research funding including a recent $750K USDA grant (2022) for PFAS mitigation research. His laboratory focuses on clay chemistry applications for environmental remediation, with notable breakthroughs in soil cleansing technologies and biochar applications. Current work emphasizes advanced contaminant degradation pathways and practical field applications of his soil modification technologies.

• Environmental Toxicology
• Reproductive Health
• Metabolic Disorders
• +۳ مورد دیگر

Dr. Alison Holloway is a Professor at McMaster University's Faculty of Health Sciences, specializing in environmental toxicology and reproductive health. Her research focuses on the effects of environmental contaminants (e.g., oil sands pollutants, pesticides, endocrine disruptors) on maternal and child health, metabolic disorders, and developmental outcomes. She has conducted studies on naphthenic acids, synthetic food additives, and maternal exposure to pharmaceuticals like fluoxetine. Key research areas include: Environmental contaminants' impact on reproductive systems and placental function Metabolic disturbances caused by chemical exposures during critical developmental windows Neurobehavioral and gastrointestinal effects of prenatal drug exposure Assessment of urban air pollution on in vitro fertilization (IVF) success rates Her recent work highlights the role of the tryptophan-kynurenine pathway as a biomarker of environmental stress and the obesogenic effects of bisphenol analogs and food additives. Collaborations involve interdisciplinary teams addressing environmental health, with studies published in high-impact toxicology and public health journals. Dr. Holloway's research has informed policies on chemical safety and maternal health, emphasizing cross-species markers for organismal health and risk assessment of emerging contaminants like cannabis derivatives.

• Neurosciences
• Physiology
• Microbiology
• +۵ مورد دیگر

Professor Elisa Hill is a distinguished academic at RMIT University where she serves as a Professor in the Department of Health and Biomedical Sciences within the College of Science. She leads the Gut-Brain Axis Laboratory and holds the significant position of Deputy Chair of the Academic Board at RMIT University. Her career spans prestigious institutions including The University of Melbourne and research collaborations in Paris, France. Professor Hill earned her PhD in Neuroscience from The University of Melbourne in 2002. She subsequently undertook a CNRS postdoctoral position in Paris studying cortical neuronal diversity. Returning to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow, she joined Prof Steve Petrou's laboratory to investigate neuronal networks in genetic mouse models of epilepsy. In 2009, she imported the Neuroligin-3R451C mouse model of autism to Australia, establishing herself as a pioneer in gut-brain axis research. Her research program focuses on three interconnected areas: identifying causes of gut dysfunction in transgenic mouse models of neurological disease, determining how neurons communicate with the lymphoid system and inflammation, and understanding interactions between the nervous system and bacteria. Professor Hill has demonstrated that gene variations associated with autism alter neuron populations in the mouse enteric nervous system, affecting gut motility, permeability, microbiome composition, and behavior. Her laboratory has developed sophisticated capabilities including video-imaging assays for gut motility, immunofluorescence for neuronal and immune cell analysis, and whole-cell patch clamp electrophysiology for neuronal activity profiling. Analysis of her recent publications reveals a strong focus on the gut-brain axis in autism, with particular attention to the Neuroligin-3R451C mouse model. Her work spans neuroimmunology, gastrointestinal physiology, microbiome interactions, and behavioral neuroscience, demonstrating an increasingly interdisciplinary approach that integrates molecular, cellular, and systems-level perspectives. A notable trend is the expansion of her research into translational applications, including biomaterial development for urogynaecological health. NHMMRC Howard Florey Centenary Fellowship ARC Future Fellowship RMIT Senior Vice Chancellor's Research Fellowship Professor Hill actively supervises numerous PhD students including Vic Lin, Yuansong Li, and Mohammed Al Alamoudi, among others. Her research has been supported by major funding bodies including NHMRC, US Department of Defense CDMRP, CNRS, ARC, and RMIT. She leads the Gut-Brain Axis Laboratory, which collaborates extensively with researchers across institutions, particularly with Prof Ashley Franks at La Trobe University. The laboratory employs a multidisciplinary team with expertise in neuroscience, microbiology, immunology, and gastrointestinal physiology, utilizing advanced techniques to investigate the complex interactions between the nervous system, immune system, and gut microbiome.

Mark Morrisonمشاهده پروفایل

استاد مدعو

• Biomedical and Clinical Sciences
• Clinical microbiology
• Gastroenterology and hepatology
• +۳ مورد دیگر

Professor Mark Morrison is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland, and holds roles as Chair & Group Leader of Metagenomics at the Frazer Institute within the Faculty of Health, Medicine and Behavioural Sciences. His research focuses on clinical microbiology, gastroenterology, and the microbiome’s role in diseases like inflammatory bowel disease (IBD) and diabetes. He has extensive academic qualifications, including a Bachelor of Science from the University of New South Wales, a Master’s from James Cook University, and a PhD from the University of Illinois. Education : Bachelor of Science, University of New South Wales Masters (Research) of Science, James Cook University Doctor of Philosophy, University of Illinois His research interests span microbiome-driven health and disease mechanisms, particularly in gut-brain interactions, mucosal microbiota dynamics, and translational therapies. Over 390 works include studies on dietary FODMAP effects, microbiome-based IBD diagnostics, and SCFA therapy for diabetes. He leads interdisciplinary grants on microbiome manipulation and has advised numerous PhD students on topics like Crohn’s disease, archaeal biodiversity, and immune modulation. His recent articles highlight microbiota roles in SIBO, anastomotic leaks, and probiotic efficacy. While no explicit awards are cited, his contributions to gut microbiome science are recognized through active research collaborations and funding. He actively supervises students and chairs teams advancing metagenomics and clinical applications.

Stefan Franceمشاهده پروفایل

استاد

• Organic Chemistry
• Synthetic Methods Development
• Natural Products Synthesis
• +۳ مورد دیگر

Stefan France serves as Professor and Associate Chair for Graduate Studies in the School of Chemistry and Biochemistry at Georgia Institute of Technology, where he leads an active research program spanning organic synthesis methodology, natural products, and medicinal chemistry. His work develops innovative carbon-carbon and carbon-heteroatom bond formations for therapeutic applications targeting cancer, HIV, diabetes, and neurological disorders. Education: B.S. Chemistry, Duke University, 2000 M.A. Chemistry, Johns Hopkins University, 2003 Ph.D. Chemistry, Johns Hopkins University, 2005 France's research integrates three interconnected pillars: Method Development focuses on efficient catalytic transformations; Natural Product Synthesis targets biologically active complex molecules through modular approaches; Medicinal Chemistry develops drug candidates via interdisciplinary collaborations. Recent trends emphasize green chemistry applications, forensic pharmaceutical analysis, and heterocyclic synthesis methodologies, particularly in dearomatization, cycloadditions, and sustainable catalysis. His publications reveal growing emphasis on environmentally conscious synthesis, forensic standards development for controlled substances, and atmospheric chemistry of organic nitrates, reflecting interdisciplinary impact across pharmaceutical, environmental, and analytical domains. Scientific Awards: NSF CAREER Award (2011) and multiple Georgia Tech teaching honors including Senior Faculty Outstanding Undergraduate Mentor (2015) NOBCChE Lloyd N. Ferguson Young Scientist Award (2012) and NIH diversity grants ORAU Powe Fellowship (2009) and Ford Foundation Dissertation Fellowship (2004) As Associate Chair for Graduate Studies, France mentors numerous students and directs curriculum development. His research has secured significant funding from NSF, NIH, and industry partners, supporting collaborative projects with biologists and computational chemists for therapeutic development. The France Lab maintains strong industry partnerships for translational research. The France Lab operates under four foundational pillars: Creating Impact through Research and Teaching, Building Platforms for Future Chemists, Collaborative Decision Making, and Inclusive Community Leadership. Active as of Spring 2025, the lab maintains a public Instagram presence showcasing its supportive, diverse research environment focused on advancing chemical synthesis while training next-generation scientists.

• Medicinal Chemistry
• Organic Chemistry
• Drug Discovery
• +۵ مورد دیگر

Prof. Dr. Rainer Riedl is the Head of the Competence Center for Drug Discovery and Organic & Medicinal Chemistry at the Zurich University of Applied Sciences (School of Life Sciences and Facility Management) . He leads numerous drug development projects targeting acute myeloid leukemia , Alzheimer's disease , antimicrobial resistance , and infectious diseases , with a focus on peptide therapeutics , targeted protein degradation , and structure-based drug design . His research combines medicinal chemistry and natural product-inspired design to develop antiviral agents (including against SARS-CoV-2 ), anti-inflammatory compounds , and novel antimicrobial delivery systems using extracellular vesicles . He has pioneered computational frameworks like CyBy2 for chemical data management and contributed to inhibitor development for matrix metalloproteinases and SENPs . Recent peer-reviewed publications highlight his work in drug resistance mechanisms , peptide engineering , and innovative antiviral strategies . He holds multiple international patents for CD93 inhibitors , skin cancer treatments , and antifungal compounds , reflecting translational impact of his research.

Kathleen M. Caronمشاهده پروفایل

استاد

• Cell Biology
• Physiology
• Lymphatic System
• +۵ مورد دیگر

Kathleen M. Caron is a Professor and Chair of the Department of Cell Biology and Physiology at the University of North Carolina (UNC) School of Medicine. Her research focuses on G protein-coupled receptor (GPCR) pathways, particularly adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) signaling, in lymphatic vascular development and gastrointestinal biology. University: University of North Carolina at Chapel Hill School: UNC School of Medicine Department: Department of Cell Biology and Physiology Research Interests: Dr. Caron's work investigates GPCR systems in lymphatic endothelial cell function, lymphangiogenesis, and neurovascular-gastrointestinal crosstalk. Key areas include: AM-CLR-RAMP2 signaling in developmental lymphangiogenesis CGRP's role in lacteal permeability and lipid absorption Lymphatic-epithelial interactions in gastrointestinal disease Pharmacological targeting of GPCRs for vascular and metabolic disorders VE-cadherin interactome in cardiac lymphatic maintenance Neuroinflammatory mechanisms in migraine pathophysiology Scientific Contributions: Her lab discovered the first pharmacologically-tractable GPCR system (AM-CLR) in lymphatic development and identified its role in human hydrops fetalis mutations. Recent studies explore CGRP signaling in meningeal lymphatics and metabolic dysregulation in lacteal-null models. Affiliations: Member of the UNC Center for Gastrointestinal Biology and Disease (CGIBD) and contributor to interdisciplinary research at UNC.

Reilly T. Enosمشاهده پروفایل

استادیار

• Obesity
• Metabolic Disease
• Sex Differences in Metabolism
• +۹ مورد دیگر

Reilly T. Enos, PhD, is an Assistant Professor in the Department of Pathology, Microbiology & Immunology at the University of South Carolina School of Medicine. His research focuses on the molecular mechanisms of sex differences in obesity, particularly metabolic and inflammatory processes influenced by sex steroids. The Enos Lab employs rodent models and advanced metabolic phenotyping to investigate menopause-related metabolic dysfunction and complementary therapies. PhD, Exercise Science (Applied Physiology), University of South Carolina, 2013 Post-Doctoral, Complementary and Alternative Medicine in Cancer and Obesity, University of South Carolina School of Medicine, 2017 MS, Exercise Physiology, Baylor University, 2009 BS, Dietetics, University of Northern Colorado, 2010 BA, Spanish & Physical Education, College of Wooster, 2007 Dr. Enos’s research spans immunometabolism, obesity, cancer cachexia, and gut microbiota. His work explores how dietary components (e.g., quercetin, emodin), hormonal status (especially estrogen), and immune modulation (e.g., miR-155, macrophages) influence metabolic and oncological outcomes. He investigates sex-specific responses to high-fat diets, inflammation, and therapeutic interventions using transgenic and diet-induced mouse models. His recent publications highlight trends in metabolic physiology, inflammation, and cancer, often examining the interplay between adipose tissue, immune cells, and hormonal regulation. Key themes include the impact of vivarium conditions on reproducibility, the role of microRNAs in tumorigenesis, and the safety and efficacy of natural compounds. Dr. Enos has not been awarded any listed scientific prizes or fellowships in the provided texts. He advises a research team focused on metabolic and inflammatory disease models, frequently collaborating with researchers such as Erin A. Murphy and Kandy T. Velázquez. His lab receives funding for studies on obesity, cancer, and complementary medicine, though specific grants are not detailed. The lab is equipped for metabolic phenotyping and rodent model studies. The Enos Lab is dedicated to understanding sex-specific metabolic regulation and developing targeted therapies for obesity and cancer-related metabolic disorders, with a focus on translational relevance and experimental rigor.

• Neurochemistry
• Alzheimer's Disease
• Biomarker Research
• +۳ مورد دیگر

Javier Saez Valero is a Professor in the Department of Biochemistry and Molecular Biology at Miguel Hernandez University of Elche, where he also serves as Deputy Vice Rector for Research - Management of Research and Transfer. His academic roles include teaching Biochemistry I in the Bachelor's in Medicine program and courses in the Master's in Neuroscience and Master's in Translational Neuropsychopharmacology, while coordinating the Doctorate in Neuroscience program. His research focuses on neurochemical mechanisms in neurodegenerative disorders, particularly Alzheimer's disease biomarker discovery in cerebrospinal fluid and blood. Key areas include NMDA receptor dynamics, ACE2 fragments, apolipoprotein E interactions, and reelin signaling pathways. His work bridges molecular biochemistry with clinical neurology to develop diagnostic tools and understand disease pathogenesis. Analysis of his 15 most recent publications (2023-2025) reveals a dominant focus on Alzheimer's disease biomarkers, especially CSF protein alterations (nicastrin, ADAM10, ACE2). Significant themes include synaptic vs extrasynaptic receptor distributions, COVID-19 neurological impacts, and nanocarrier drug delivery limitations. His work consistently targets translational applications for early diagnosis and therapeutic development. No scientific awards were documented in the provided information. Professor Saez Valero provides academic guidance through tutorials and course coordination across undergraduate, master's, and doctoral programs. As Doctorate in Neuroscience coordinator, he oversees research training while managing institutional research transfer activities through the Vice Rectorate. His teaching spans biochemistry, neuropathology, and molecular neuroscience with laboratory components. He operates from Laboratory 241 at the Institute of Neurosciences (Campus de San Juan), a joint research center with CSIC. His work integrates with the university's Vice Rectorate for Research and Transfer, facilitating technology transfer and collaborative neuroscience research within the university's research infrastructure.

Annette Liesegangمشاهده پروفایل

استاد

• Bone Metabolism
• Mineral Nutrition
• Animal Nutrition
• +۳ مورد دیگر

Prof. Dr. Annette Liesegang serves as a Professor at the Institute of Animal Nutrition and Dietetics within the Vetsuisse Faculty of the University of Zurich. Her research focuses on bone and cartilage physiology, obesity, and clinical nutrition impacts across multiple animal species including ruminants, dogs, reptiles, pigs, and birds. Her primary research interests encompass bone metabolism, mineral nutrition, comparative physiology, and veterinary diagnostics. She specializes in bone marker analysis, bone mineral density measurement via quantitative peripheral computed tomography, and calcium absorption mechanisms using immunohistochemical methods. Her work investigates physiological and nutritional influences on bone resorption/formation dynamics during critical periods like gestation and lactation, with extensive species-specific expertise. Analysis of her 2024-2025 publications reveals dominant research themes in calcium metabolism (particularly in sheep/goats), urolithiasis pathogenesis across species, vitamin D optimization, and clinical dietary interventions for conditions like intestinal malabsorption. Methodological innovations include in-vitro digestion models and UVB-irradiated feed development, reflecting her translational approach from basic bone physiology to practical animal nutrition solutions. Scientific awards: No scientific awards were documented in the provided materials. Prof. Liesegang mentors thesis students and leads collaborative research projects, notably with Prof. Brigitte von Rechenberg on growth plate physiology in foals and lambs. Her work leverages institutional facilities including specialized CT equipment and laboratory infrastructure for biochemical analysis, though specific grant details remain unreported in the source text. The Institute of Animal Nutrition and Dietetics operates dedicated animal research facilities with stables for multiple species and managed sheep/goat herds under veterinary supervision. These resources enable controlled studies on bone metabolism, dietary interventions, and species-specific nutrition, supporting her extensive publication record in veterinary and comparative nutrition science.

Savanna Thorمشاهده پروفایل

استادیار

• Pelvic Floor Dysfunction
• Constipation
• Fecal Incontinence
• +۶ مورد دیگر

Dr. Savanna Thor serves as Assistant Professor of Medicine and Program Director of the GI Fellowship Program within the Department of Gastroenterology and Hepatology at SUNY Downstate Health Sciences University's School of Medicine. She specializes in advanced endoscopic diagnostics and treatment of gastrointestinal disorders through the Digestive Disease Center. Her educational background includes: Doctor of Osteopathic Medicine (DO) from Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania Internal Medicine Residency at Drexel University/Hahnemann University Hospital, Philadelphia, Pennsylvania Gastroenterology and Hepatology Fellowship at Drexel University/Hahnemann University Hospital, Pennsylvania (serving as Chief Fellow) Dr. Thor's clinical expertise focuses on complex motility disorders including pelvic floor dysfunction, swallowing abnormalities, and anorectal conditions. Her research integrates patient education with health disparities analysis in gastrointestinal care, particularly for colorectal cancer screening accessibility and functional GI diseases. Procedural capabilities span upper endoscopy, colonoscopy, esophageal/anorectal manometry, capsule endoscopy, and impedance testing. As Fellowship Program Director, she oversees gastroenterology trainee development while maintaining active clinical practice. Her work emphasizes translating motility disorder research into practical patient management strategies for conditions like chronic constipation and fecal incontinence within underserved populations.

Vernon Chinchilliمشاهده پروفایل

استاد

• Biostatistics
• Clinical Trials
• Multivariate Analysis
• +۴ مورد دیگر

Vernon M. Chinchilli is a Distinguished Professor of Public Health Sciences and Professor of Statistics at The Pennsylvania State University. He holds appointments in the Department of Public Health Sciences (Division of Biostatistics and Bioinformatics) and the Department of Statistics. His primary affiliation is with the College of Medicine. Dr. Chinchilli received his PhD in Statistics from the University of North Carolina at Chapel Hill (1979) and a BS in Mathematics from Penn State (1974). His research focuses on biostatistical methodology for multi-center clinical trials, multivariate analysis of longitudinal data, and statistical methods for crossover designs. He has led NIH-funded Data Coordinating Centers for studies on lung disease, kidney disease, and acute kidney injury (AKI). Notable roles include Principal Investigator for the Natural History of AKI Consortium and the Biostatistics Research Center for Impaired Awareness of Hypoglycemia. Dr. Chinchilli teaches doctoral courses in multivariate analysis (PHS 523) and statistical methods in public health (PHS 554/555). He has advised 35 PhD and 40 MS students. His honors include Fellow of the American Statistical Association (1997) and extensive contributions to methodological advancements in clinical trial design and analysis. Key areas of investigation include: 1) statistical methods for agreement assessment and equivalence testing in clinical trials, 2) biomarker development for kidney function decline, and 3) application of machine learning in predicting post-hospitalization outcomes. He collaborates internationally on projects like the ENICTO cancer treatment outcomes initiative and the S-AKI sepsis biomarker study. Recent work explores: cognitive change measurement in aging populations, opioid alternative therapies for chronic pain, and vaccine efficacy in immunocompromised patients. His research spans 541 peer-reviewed publications and 15 active NIH grants, with particular emphasis on translating statistical innovations into clinical practice.

• Neuroscience
• Neurocardiology
• Gut-Brain Axis
• +۵ مورد دیگر

Rui Chang is an Associate Professor at Yale University School of Medicine , jointly appointed in the Department of Neuroscience and Department of Cellular and Molecular Physiology . His research focuses on organ-to-brain circuits and neurocardiology with specific interest in Parkinson's disease . He completed his B.S. in Biological Sciences at Tsinghua University (2005) Ph.D. in Neuroscience at University of Southern California (2011) Postdoctoral training in the lab of Stephen Liberles at Harvard Medical School (2017) Research Highlights: The Chang lab employs single-cell gene expression profiling , virus-based anatomical mapping , and optogenetics to investigate vagal interoceptive systems and their roles in cardiovascular regulation and gut-brain axis dysfunction in neurodegenerative diseases. Their work has revealed a multidimensional coding architecture for visceral sensory signals. Notable Scientific Awards: McKnight Neurobiology of Brain Disorders Award (2021) NIH Director’s New Innovator Award (2019) Kavli Faculty Innovative Research Award (2019) NIH K01 Mentored Research Scientist Award (2017) Keystone Symposia Future of Science Scholarship (2016) Collaborative Network: Chang collaborates with experts in neurodegeneration (David A. Hafler, MD), biostatistics (Hongyu Zhao, PhD), and neural imaging (Le Zhang, PhD). His work intersects with the Stephen & Denise Adams Center for Parkinson’s Disease Research and Kavli Institute for Neuroscience .